Literature DB >> 31024325

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines.

.   

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.01202.].

Entities:  

Keywords:  G protein-coupled receptor; cannabinoid receptor 2 (CB2); drug design; immune therapeutics; medicinal chemistry; signalling; signalling bias; synthetic cannabinoid

Year:  2019        PMID： 31024325      PMCID： PMC6460767          DOI： 10.3389/fphar.2019.00418

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN： 1663-9812            Impact factor:   5.810


Due to a production error, 24 references with more than six authors were listed in the Reference list without “et al.” The references affected are Bouaboula et al. (1993, 1996); Felder et al. (1995); Galiegue et al. (1995); Favata et al. (1998); Portier et al. (1999); Kilts et al. (2002); Karsak et al. (2005); Wright et al. (2005); Ofek et al. (2006); Jiang et al. (2007); Valant et al. (2008); Cencioni et al. (2010); Hurst et al. (2010); Schuehly et al. (2011); van der Stelt et al. (2011); Kleyer et al. (2012); Odan et al. (2012); Shonberg et al. (2013); Brailoiu et al. (2014); Herenbrink et al. (2016); Finlay et al. (2017); Soethoudt et al. (2017) and Yrjölä et al. (2015). The publisher apologizes for this mistake. The original version of this article has been updated.
  24 in total

1.  Cannabinoid receptor trafficking in peripheral cells is dynamically regulated by a binary biochemical switch.

Authors:  Jonas Kleyer; Simon Nicolussi; Peter Taylor; Deborah Simonelli; Evelyne Furger; Pascale Anderle; Jürg Gertsch
Journal:  Biochem Pharmacol       Date:  2012-02-24       Impact factor: 5.858

2.  Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent.

Authors:  Masahide Odan; Natsuki Ishizuka; Yoshiharu Hiramatsu; Masanao Inagaki; Hiroshi Hashizume; Yasuhiko Fujii; Susumu Mitsumori; Yasuhide Morioka; Masahiko Soga; Masashi Deguchi; Kiyoshi Yasui; Akinori Arimura
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

3.  Peripheral cannabinoid receptor, CB2, regulates bone mass.

Authors:  Orr Ofek; Meliha Karsak; Nathalie Leclerc; Meirav Fogel; Baruch Frenkel; Karen Wright; Joseph Tam; Malka Attar-Namdar; Vardit Kram; Esther Shohami; Raphael Mechoulam; Andreas Zimmer; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

4.  Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Keng-Mean Lin; Dianne DeCamp; Tamara Roach; Robert Hsueh; Robert A Rebres; Elliott M Ross; Ronald Taussig; Iain Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2007-02-05       Impact factor: 5.157

5.  SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.

Authors:  M Portier; M Rinaldi-Carmona; F Pecceu; T Combes; C Poinot-Chazel; B Calandra; F Barth; G le Fur; P Casellas
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

6.  Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.

Authors:  M Bouaboula; C Poinot-Chazel; J Marchand; X Canat; B Bourrié; M Rinaldi-Carmona; B Calandra; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1996-05-01

7.  Cannabinoid-receptor expression in human leukocytes.

Authors:  M Bouaboula; M Rinaldi; P Carayon; C Carillon; B Delpech; D Shire; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1993-05-15

8.  Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists.

Authors:  Wolfgang Schuehly; Juan Manuel Viveros Paredes; Jonas Kleyer; Antje Huefner; Sharon Anavi-Goffer; Stefan Raduner; Karl-Heinz Altmann; Jürg Gertsch
Journal:  Chem Biol       Date:  2011-08-26

9.  The role of kinetic context in apparent biased agonism at GPCRs.

Authors:  Carmen Klein Herenbrink; David A Sykes; Prashant Donthamsetti; Meritxell Canals; Thomas Coudrat; Jeremy Shonberg; Peter J Scammells; Ben Capuano; Patrick M Sexton; Steven J Charlton; Jonathan A Javitch; Arthur Christopoulos; J Robert Lane
Journal:  Nat Commun       Date:  2016-02-24       Impact factor: 14.919

10.  Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Authors:  Marjolein Soethoudt; Uwe Grether; Jürgen Fingerle; Travis W Grim; Filomena Fezza; Luciano de Petrocellis; Christoph Ullmer; Benno Rothenhäusler; Camille Perret; Noortje van Gils; David Finlay; Christa MacDonald; Andrea Chicca; Marianela Dalghi Gens; Jordyn Stuart; Henk de Vries; Nicolina Mastrangelo; Lizi Xia; Georgios Alachouzos; Marc P Baggelaar; Andrea Martella; Elliot D Mock; Hui Deng; Laura H Heitman; Mark Connor; Vincenzo Di Marzo; Jürg Gertsch; Aron H Lichtman; Mauro Maccarrone; Pal Pacher; Michelle Glass; Mario van der Stelt
Journal:  Nat Commun       Date:  2017-01-03       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.